Correlation Between Takeda Pharmaceutical and NuCana PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and NuCana PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and NuCana PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and NuCana PLC, you can compare the effects of market volatilities on Takeda Pharmaceutical and NuCana PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of NuCana PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and NuCana PLC.

Diversification Opportunities for Takeda Pharmaceutical and NuCana PLC

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Takeda and NuCana is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and NuCana PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NuCana PLC and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with NuCana PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NuCana PLC has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and NuCana PLC go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and NuCana PLC

Considering the 90-day investment horizon Takeda Pharmaceutical is expected to generate 2.83 times less return on investment than NuCana PLC. But when comparing it to its historical volatility, Takeda Pharmaceutical Co is 15.39 times less risky than NuCana PLC. It trades about 0.01 of its potential returns per unit of risk. NuCana PLC is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  945.00  in NuCana PLC on September 2, 2024 and sell it today you would lose (815.00) from holding NuCana PLC or give up 86.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Takeda Pharmaceutical Co  vs.  NuCana PLC

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
NuCana PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NuCana PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Takeda Pharmaceutical and NuCana PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and NuCana PLC

The main advantage of trading using opposite Takeda Pharmaceutical and NuCana PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, NuCana PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuCana PLC will offset losses from the drop in NuCana PLC's long position.
The idea behind Takeda Pharmaceutical Co and NuCana PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments